Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 7 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 12151062

    Compositions and devices to administer pharmaceutical compositions nasally

    The Board of Regents of the University of Texas System · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  2. US 12144800

    Inhibiting germination of Clostridium perfringens spores to reduce necrotic enteritis

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  3. US 12146139

    Oligonucleotide interference treatments of prostate cancer

    The Board of Regents of the University of Oklahoma · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  4. US 12144828

    Human Kynureninase enzymes and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  5. US 12138274

    Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  6. US 12139764

    Systems and methods for characterizing and treating breast cancer

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  7. US 12134648

    Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  8. US 12134609

    Quinoline cGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  9. US 12133924

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  10. US 12121580

    Antibacterial photodynamic therapy using copper-cysteamine nanoparticles

    The Board of Regents of the University of Texas System · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  11. US 12121525

    Methods for treating GI syndrome and graft versus host disease

    The Board of Regents of the University of Texas System · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  12. US 12116597

    Autophagy as a therapeutic target for intracranial aneurysm

    The Board of Regents of the University of Texas System · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  13. US 12116604

    Transposase polypeptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  14. US 12116423

    Ang (1-7) derivative oligopeptides and methods for using and producing the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  15. US 12102617

    Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  16. US 12104181

    Compositions and methods for treating viral infections targeting TRIM7

    The Board of Regents of the University of Texas System · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  17. US 12098138

    Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases

    The Board of Regents of the University of Texas System · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  18. US 12097213

    Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy

    The Board of Regents of the University of Texas System · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  19. US 12091486

    Block copolymer and micelle compositions and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  20. US 12090142

    Combination therapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  21. US 12091387

    Quinoline cGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  22. US 12084514

    Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  23. US 12084691

    Modulating human Cas9-specific host immune response

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  24. US 12084490

    Antibody based reagents that specifically recognize toxic oligomeric forms of tau

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted